Insulet Corp
PODD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001145197
In the last 90 days, Insulet Corp insiders filed 1 open-market purchase and 0 sales; 731 institutions reported holding it in 13F filings for Q2 2026, worth $10.9B in total; no superinvestor holds it.
Holders of 5% or more of PODD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Insulet Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Capital Research Global Investors | 13G/A | 6.70%4.74M shares | −2.00 ppfrom 8.70% | May 13, 20252 filings | Aug 13, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Insulet Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 27, 20269:51 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −12.49 ppfrom 12.49%Below 5% | Mar 13, 2026 | SEC |
| Oct 30, 20253:16 PM ET | Vanguard Group Inc | 13G/A | 12.49%8.80M shares | – | Sep 30, 2025 | SEC |
| Aug 13, 202511:39 AM ET | Capital Research Global Investors | 13G/A | 6.70%4.74M shares | −2.00 ppfrom 8.70% | Jun 30, 2025 | SEC |
| May 13, 202511:32 AM ET | Capital Research Global Investors | 13G/A | 8.70%6.08M shares | – | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Insulet Corp shares.
No Form 144 notices for Insulet Corp are on file.